Skip to main content
SpringerLink
Log in
Book cover

Hypertensive Cardiovascular Disease: Pathophysiology and Treatment pp 277–289Cite as

Role of Obesity in the Pathogenesis of Primary Hypertension

  • Chapter

  • 232 Accesses

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 16))

Abstract

In the past, the obese have been considered to be of jovial and easy-going character. Yet, they seem to pay heavily for these social qualities as far as their physical health is concerned. Obesity was dismissed as a contributor to disease [1], due to the lack of a direct cause-and-effect relationship and because the association of obesity with disease was largely epidemiological. In this context, Mann[l] distinguishes between causation and association, and claims that obesity is an inevitable and incurable condition, at least in western society. He maintains that treatment is so ineffective that its influence on any disease process cannot be evaluated. Berger[2], in his review at the 3rd International Congress on Obesity, claimed that the higher mortality rates in obesity were only associated with an overweight which exceeded the ideal body weight by at least 25–30%. Van Itallie, however, found that even 10% over the ideal weight was associated with higher mortality rates [3]. He compared mortality rates according to variations in body weight in three separate studies: the Build and Blood Pressure Study [4], The American Cancer Society Study [5] and the Build Study [4]. From their tables it can be seen that at 10% overweight, the mortality percentage is 113, 107 and 111 respectively for males and 109, 108 and 107 respectively for females. At 30% overweight these figures increase to 142, 137 and 135 respectively for males and 130, 138 and 125 respectively for females.

He is fat and scant of breath. Hamlet, V, 2, 298.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mann GV: The influence of obesity on health. N Engl J Med 291:178–185, 226–232, 1974.

    Google Scholar 

  2. Klesse R, Berchtold P, Dannehl K, Gebler S, Greiser E, Berger M, Jörgens V, Gries FA, Zimmermann H: Mortality of obese patients: the Düsseldorf mortality study. 3rd International Congress of Obesity. Alim Nutr Metab 1: 291, 1980.

    Google Scholar 

  3. Van Itallie TB: Obesity: adverse effects on health and longevity. Am J Clin Nutr 32: 2723–2733, 1979.

    PubMed  Google Scholar 

  4. Build and blood pressure studies 1957. vol. 1. Chicago: Society of Actuaries, 1959.

    Google Scholar 

  5. Lew EA, Garfinkel L: Variations in mortality by weight among 750,000 men and women. J Chronic Dis 32: 563–576, 1979.

    Article  PubMed  CAS  Google Scholar 

  6. Richards R, DeCasseres M: The Problem of Obesity in developing countries: its prevalence and morbidity. In: Obesity Symposium, pp. 74–84. Burland WL, Samuel PD, Yudkin J, eds. Edinburgh: Churchill Livingstone, 1974.

    Google Scholar 

  7. Kannel WB, Gordon T: Obesity and cardiovascular disease: the Framingham Study. Clin Endocrinol Metab 5: 367–75, 1976.

    Article  PubMed  Google Scholar 

  8. Berchtold P, Bergman M, Greiser M, Dobse M, Irmscher K, Gries FA, Zimmerman H: Cardiovascular risk factors in gross obesity. Int J Obesity 1: 291, 1977.

    Google Scholar 

  9. Kannel WB, Brand N, Skinner JJ, Dawber TR, McNamare PM: The relation of adiposity to blood pressure and development of hypertension. Ann Intern Med 67: 48–59, 1967.

    PubMed  CAS  Google Scholar 

  10. Pelkonen R, Nikkila EA, Koskinin S, Penttinen K, Sarna S: Association of serum lipids and obesity with cardiovascular mortality. Br Med J 2: 1185–1187, 1977.

    Article  PubMed  CAS  Google Scholar 

  11. Zwillich CW, Sutton FD, Pierson DJ, Creagh EM, Weil JV: Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome. Am J Med 59: 343–348, 1975.

    Article  PubMed  CAS  Google Scholar 

  12. Kannel WB, Gordon T: Obesity and cardiovascular disease: the Framingham Study. In: Obesity Symposium,pp. 24–51. Burland WL, Samuel PD, Yudkin J, eds. Edinburgh: Churchill Livingstone, 1974.

    Google Scholar 

  13. Miettinen TA: Cholesterol production in obesity. Circulation 44: 842–850, 1971.

    PubMed  CAS  Google Scholar 

  14. Friedman GD, Kannel WB, Dawber TR: The epidemiology of gallblader disease: observations in the Framingham Study. J Chr Dis 19: 273–292, 1966.

    Article  CAS  Google Scholar 

  15. Leach RE, Baumgard S, Broom J: Obesity: its relationship to osteoarthritis of the knee. Clin Orthop 93: 217, 1973.

    Google Scholar 

  16. Pickering GW.High Blood Pressure. London: Churchill, 1955.

    Google Scholar 

  17. Adlesberg D, Colcher HR, Laval J: Effect of weight reduction on course of arterial hypertension. J Mount Sinai Hosp (N.Y.) 12: 984–992, 1946.

    Google Scholar 

  18. Lew EA: High blood pressure, other risk factors and longevity. The insurance view point. Am J Med 55: 281–294, 1973.

    Article  PubMed  CAS  Google Scholar 

  19. Epstein FH, Francis T, Hayner NS, Johnson BC, Kjelsberg MO, Napier JA, Ostrander LD, Payne MW, Dodge HJ: Prevalence of chronic diseases and distribution of selected physiological variables in a total community, Tecumseh, Michigan. Am J Epidemiol 81: 307–322, 1965.

    PubMed  CAS  Google Scholar 

  20. Epstein FH: Estimating the effect of preventing obesity on total mortality and hypertension. Int J Obesity 3: 163–166, 1979.

    CAS  Google Scholar 

  21. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B: Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 298: 1–6, 1978.

    Article  PubMed  CAS  Google Scholar 

  22. Iaina A, Goldfarb D, Gaon T, Shochat J, Eliahou HE: Low energy diet in the essential hypertension patient. Third International Congress on Obesity. Rome, 8–11 Oct., 1980.

    Google Scholar 

  23. Ramsay LE, Ramsay MH, Hettiarchi J, Davies DL, Winchester J: Weight reduction in a blood pressure clinic. Br Med J 2: 244–245, 1978.

    Article  PubMed  CAS  Google Scholar 

  24. Linet Ol, Metzler CM, Vantasset M: Evaluation of a ‘free’ weight control clinic. Obesity/Bariatric Med 8: 152–157, 1979.

    Google Scholar 

  25. Eliahou HE, Iaina A, Gaon T, Shochat J, Modan M: Body Weight reduction necessary to attain normotension in the overweight hypertensive patient. Obesity and Hypertension, Satellite Symposium tothe Third International Congress on Obesity in Rome. Florence, 6–7 Oct., 1980.

    Google Scholar 

  26. Chiang BN, Perlman LV, Epstein FH: Overweight and hypertension. A review. Circulation 39: 403–421, 1969.

    PubMed  CAS  Google Scholar 

  27. Kaltman AJ, Goldring RM: Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med 60: 645–653, 1976.

    Article  PubMed  CAS  Google Scholar 

  28. Dustan HP: Hemodynamics in obesity. Obesity and Hypertension, Satellite Symposium to the Third International Congress on Obesity. Florence, 6–7, Oct., 1980.

    Google Scholar 

  29. De Fronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ: The effect of insulin or renal handling of sodium, potassium, calcium and phosphate in man. J Clin Invest 55: 845–855, 1975.

    Article  Google Scholar 

  30. Kolanowski J, Salvador G, Desmecht P, Henquin JC, Crabbe J: Influence of glucagon on natriuresis and glucose-induced sodium retention in the fasting obese subject. Eur J Clin Invest 7: 167–175, 1977.

    Article  PubMed  CAS  Google Scholar 

  31. Sims EAH, Danforth E, Horton ES, Bray GA, Glennon JA, Salans LB: Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 29: 457–496, 1973.

    PubMed  CAS  Google Scholar 

  32. De Fronzo RA: Effect of insulin and glucagon on electrolytes and blood pressure in experimental animals. Obesity and Hypertension, Satellite Symposium to the Third International Congress on Obesity. Florence, 6–7 Oct., 1980.

    Google Scholar 

  33. Krotkiewski M, Mandroukas M, Sjöström L, Sullivan H, Witterquist H, Björntorp P, Wilhelmsen L: Effects of long-term physical training on body fat, metabolism and blood pressure in obesity. Metabolism 28: 649–658, 1979.

    Article  Google Scholar 

  34. Dahl LK, Silver L, Cristie RW: Role of salt in the fall of blood pressure accompanying reduction in obesity. N Engl J Med 258: 1186–1192, 1958.

    Article  PubMed  CAS  Google Scholar 

  35. Tobian L: The relationship of salt to hypertension. Am J Clin Nutr 32: 2739–2748, 1979.

    PubMed  CAS  Google Scholar 

  36. Takahashi E, Sasaki N, Takeda J, Ito H: The geographic distribution of cerebral hemorrhage and hypertension in Japan. Hum Biol 29: 139, 1957.

    PubMed  CAS  Google Scholar 

  37. Shaper AG: Cardiovascular disease inthe tropics - III. Blood pressure and hypertension. Br Med J 3: 805–807, 1972.

    Article  PubMed  CAS  Google Scholar 

  38. Kempner W: Treatment of kidney disease and hypertensive vascular disease with rice diet. N Carolina Med J 5: 125–133, 1944.

    Google Scholar 

  39. Murphy RFJ: The effect of’rice diet’ on plasma volume and extracellular fluid space in hypertensive subjects. J Clin Invest 29: 912–917, 1950.

    Article  PubMed  CAS  Google Scholar 

  40. Page IH: Some regulatory mechanisms of renovascular and essential arterial hypertension. In: Hypertension, pp. 576–587. Genest J, Koiw E, Kuchel O, eds. New York: McGraw Hill, 1977.

    Google Scholar 

  41. Dornfeld LS, Kushiro T, Yanagava N, Waks AU, Vertes V, Maxwell MH: Blood pressure changes in obese subjects during rapid weight reduction. Third International Congress on Obesity. Rome 8–11 Oct., 1980. Alim Nutr Matab 1: 254, 1980.

    Google Scholar 

  42. Tobian L, Lange J, Iwai J, Hiller K, Johnson MA, Goossens P: Prevention with thiazide of NaCl-induced hypertension in Dahl ‘S’ rats. Hypertension 1: 316–323, 1979.

    PubMed  CAS  Google Scholar 

  43. Fujita T, Henry WL, Barther FC, Lake CR, Delea CS: Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 69: 334–343, 1980.

    Article  PubMed  CAS  Google Scholar 

  44. Landsberg L: Nutrition and regulation of the sympathetic nervous system and its relation to hypertension. Obesity and Hypertension, Satellite Symposium to the Third International Congress on Obesity. Florence, 6–7 Oct., 1980.

    Google Scholar 

  45. Sims EAH: Mechanisms of hypertension in the syndromes of obesity. An overview. Obesity and Hypertension, Satellite Symposium tothe Third International Congress on Obesity. Florence, 6–7 Oct., 1980.

    Google Scholar 

  46. Horton ES: The role of exercise inthe treatment of hypertension in obesity. Obesity and Hypertension, Satellite Symposium to the Third International Congress on Obesity. Florence, 6–7 Oct., 1980.

    Google Scholar 

  47. Danforth E Jr, Horton ES, O’Connell M, Sims EAH, Banger AG, Ingbar SH, Braverman L, Vagenakis AG: Dietary-induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest 64: 1336–1347, 1979.

    Article  PubMed  CAS  Google Scholar 

  48. Sims EAH, Phinney SD, Vaswani A: The management of hypertension associated with obesity. Int J Obesity 2: 215, 1978.

    CAS  Google Scholar 

  49. Williams LT, Lefkowitz RJ, Watanabe AM, Hathaway DR, Besch HR Jr: Thyroid hormone regulation of ß-adrenergic receptor number. J Biol Chem 252: 2787–2789, 1977.

    PubMed  CAS  Google Scholar 

  50. Williams LT, Lefkowitz RJ, Watanabe AM, Hathaway DR, Besch HR Jr: Thyroid hormone regulation of ß-adrenergic receptor number: possible biochemical basis for the hyperadrenergic state in hyperthyroidism. Clin. Res. 25 (3): 458A, 1977.

    Google Scholar 

  51. Ciaraldi T, Marinetti GV: Thyroxine and propylthiouracyl effects in vivo on α and ß-adrenergic receptors in rat heart. Biochem Biophys Res Commun 74: 984–991, 1977.

    Article  PubMed  CAS  Google Scholar 

  52. Galant SP, Duriseti L, Underwood S, Insel PA: Decreased ß-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. N Engl J Med 299: 933–936, 1978.

    Article  PubMed  CAS  Google Scholar 

  53. Williams RS, Guthrow CE, Lefkowitz RJ. ß-adrenergic receptors in human lymphocytes are unaltered by hyperthyroidism. J Clin Endocrinol Metab 48: 503–505, 1979.

    Article  PubMed  CAS  Google Scholar 

  54. Dre Luise M, Blackburn GL, Flier JS: Reduced activity of the red-cell sodium-potassium pump in human obesity. N Engl J Med 303: 1017–1022, 1980.

    Article  Google Scholar 

  55. Garay RP, Elghozi JL, Dagher G, Meyer P: Laboratory distinction between essential and secondary hypertension by measurement of erythrocyte cation fluxes. N Engl J Med 302: 769–771, 1980.

    Article  PubMed  CAS  Google Scholar 

  56. Garay RP, Dagher G, Pernollet MG, Devynck MA, Meyer P: Inherited defect in a Na+−K+ co-transport system in erythrocytes from essential hypertensive patients. Nature 284: 281–283, 1980.

    Article  PubMed  CAS  Google Scholar 

  57. Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC: Increased sodium-lithium counter transport in red cells of patients with essential hypertension. N Engl J Med 302: 772–776, 1980.

    Article  PubMed  CAS  Google Scholar 

  58. Haddy FJ: Mechanism, prevention and therapy of sodium-dependent hypertension. Am J Med 69: 746, 1980.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. E. Eliahou
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hypertension and Cardiovascular Rehabilitation Unit, Department of Pathophysiology, University of Leuven, K.U. Leuven, 3000, Leuven, Belgium

    A. Amery , R. Fagard , P. Lijnen  & J. Staessen , ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Martinus Nijhoff Publishers, The Hague

About this chapter

Cite this chapter

Eliahou, H.E. (1982). Role of Obesity in the Pathogenesis of Primary Hypertension. In: Amery, A., Fagard, R., Lijnen, P., Staessen, J. (eds) Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Developments in Cardiovascular Medicine, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7476-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-7476-0_17

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-7478-4

  • Online ISBN: 978-94-009-7476-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation